IRIS
BARISIONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.612
Totale 6.612
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.612
Totale 6.612
Salva come PNG Salva come JPEG
Città #
Genova 4.461
Rapallo 845
Genoa 754
Vado Ligure 520
Bordighera 32
Totale 6.612
Salva come PNG Salva come JPEG
Nome #
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 169
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 165
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols. 155
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 154
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 154
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 143
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 143
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 140
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 138
Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development 136
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 136
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 135
Increased neutrophil lifespan in patients with congestive heart failure. 132
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 128
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 127
Protective effects of Resveratrol in an experimental model of abdominal aortic aneurysm induction. 125
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease 123
Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6. 122
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 113
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 109
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 107
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway 107
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 103
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 101
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 101
Role of cell-cell bond for the viability and the function of vascular smooth muscle cells. 99
CD14CD16 monocyte subset levels in heart failure patients. 99
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 98
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 97
Systemic vascular inflammation in abdominal aortic aneurysm patients: a contrast-enhanced PET/CT study 92
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 92
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 91
The Genoa Vascular Biobank: A today resource for future perspectives in vascular research 89
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 89
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 89
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 88
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 87
HETEROGENEITY AND DIFFERENT RELATIONSHIP WITH BIOCHEMICAL AND INFLAMMATORY BIOMARKERS FOR THE CIRCULATING CD16+ MONOCYTES SUBSETS IN ABDOMINAL AORTIC ANEURYSMS (AAA) 87
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 87
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 83
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 83
Morphological patterns identification in PET+ aneurysmatic lesions. 82
ADVANCED ABDOMINAL AORTIC ANEURYSMS DISPLAY ASPECIFIC INFLAMMATORY-PROATHEROSCLEROTIC PROFILEWITH RENAL DYSFUNCTION, RAISED D-DIMER, EXPANDEDCD14++CD16+-MONOCYTES HAVING HIGH CD143 78
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 77
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 76
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 74
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 72
Alghe fitoplanctoniche immobilizzate nell'alimentazione di larve di Sparus aurata 71
INDOXYL SULFATE INDUCES FIBROSIS AND INFLAMMATION BY UPREGULATING HEAT SHOCK PROTEIN 90 (HSP 90) IN RENAL FIBROBLASTS 70
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 68
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 68
ACTIVATION OF THE NLRP3 INFLAMMASOME PROMOTES INFLAMMATION IN SKELETAL MUSCLE OF PATIENTS WITH CKD 67
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 65
Mobilizzazione ematica delle sottopopolazioni di progenitori di cellule endoteliali in pazienti con infarto acuto del miocardio. 64
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 64
Up-regulation of lectin-like oxidised LDL receptor-1 (LOX-1) in cardiac muscle cells and implications in doxorubicin-induced cardiotoxicity. 64
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 62
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 62
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 60
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 60
INIBIZIONE DA PARTE DEL CELECOXIB DI ALTERAZIONI INFIAMMATORIE NELL’AORTA DI TOPI ESPOSTI A FUMO DI SIGARETTA. 59
Produzione di alghe fitoplanctoniche utilizzabili per l'alimentazione di Larve di Sparus aurata 55
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 53
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 50
Le risposte infiammatorie ed ossidative indotte da un pasto iperlipidico rendono il siero postprandiale proapoptotico per le cellule endoteliali. 47
La metalloproteasi di tipo 9 proveniente dai neutrofili aumenta nei pazienti con scompenso cardiaco. 45
RIDOTTA APOPTOSI DEI LEUCOCITI POLIMORFONUCLEATI EDANNO ENDOTELIALE IN SOGGETTI AFFETTI DA SCOMPENSO CARDIACO CONGESTIZIO 45
MOBILIZZAZIONE DI CD34+ E CELLULE ENDOTELIALI CIRCOLANTI IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO 44
IL LEGAME CELLULA-CELLULA CONTRASTA GLI EFFETTI PROATEROGENICI DI ANGIOTENSINA II IN CELLULE MUSCOLARI LISCE DI AORTA DI RATTO 44
UN PASTO AD ALTO CONTENUTO LIPIDICO DIMINUISCE IL TASSO DI APOPTOSI SPONTANEA DEI LEUCOCITI POLIMORFONUCLEATI 38
null 36
Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy 34
Effects of the AhR inhibitor CH-223191 on the indoxyl sulphateinduced cardiac fibroblast activation. Role of Nrf2 31
PCSK9 and Other Metabolic Targets to Counteract Ischemia/Reperfusion Injury in Acute Myocardial Infarction and Visceral Vascular Surgery 29
Renal ischemia/reperfusion early induces myostatin and PCSK9 expression in rat kidneys and HK-2 cells 27
Engineering of poly(caprolactone) and poly(glycerol sebacate) small-diameter vascular prosthesis with quercetin 26
Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography 16
Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2 13
Totale 6.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.406
article - articoli 17.276
book - libri 0
conference - conferenze 2.909
curatela - curatele 0
other - altro 221
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.346 0 0 0 0 143 161 232 91 149 314 182 74
2020/2021416 27 37 14 33 17 30 15 33 57 66 39 48
2021/2022842 26 54 78 101 35 46 39 210 27 73 43 110
2022/20231.027 102 88 9 107 191 153 11 75 154 8 107 22
2023/2024551 15 55 12 61 31 98 47 54 45 19 40 74
2024/2025585 94 106 65 119 201 0 0 0 0 0 0 0
Totale 6.712